Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Unhealthiest Countries in Latin America

In this article, we will be taking a look at the 15 unhealthiest countries in Latin America. You can also skip our detailed analysis on the topic and directly head to the 5 Unhealthiest Countries in Latin America.

Global and Latin American Trends in Healthcare Market

The healthcare services market is expected to expand at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion, through 2027. The global healthcare market is divided into several segments, including hospitals, digital health, and healthcare services. The hospital market alone is predicted to grow by 4.18% a year between 2024 and 2029, reaching a market volume of $5.19 trillion by that point.

According to estimates from the World Health Organization (WHO), at least half of the world’s population lacks access to basic medical care. The healthcare industry in the United States is one of the largest and most complex in the world, accounting for around 20% of the country’s GDP. In 2021, patient care brought in 65% of the total revenue for the US health sector. On the other hand, the COVID-19 pandemic caused a severe financial downturn, with the US healthcare system’s revenue plummeting by almost 50% in 2020.

Latin America’s healthcare market is witnessing substantial growth driven by demographic shifts and increasing demand for healthcare services. The region’s healthcare expenditure is rising, with Brazil and Mexico leading in current healthcare spending. In 2023, the home healthcare market in Latin America was valued at USD 28.08 billion and is projected to reach USD 46.12 billion by 2029, registering a compound annual growth rate (CAGR) of 10.43%.

According to a report by McKinsey, a significant portion of healthcare costs in Latin America is borne out-of-pocket, averaging about 24% of total healthcare costs, compared to 14% in the European Union and 10% in the United States. Accessibility and affordability remain major barriers, with 62% of surveyed individuals deferring medical care due to these issues. The prevalence of chronic diseases is also increasing, necessitating more healthcare resources. The region is experiencing a demographic shift with an aging population, projected to reach 193 million people over 60 by 2050.

Key Players in the Global Healthcare Market 

Key players like AbbVie Inc. (NYSE:ABBV), Humana Inc., and UnitedHealth Group Incorporated (NYSE:UNH), among others, have been at the forefront of the healthcare market. For example, AbbVie Inc. (NYSE:ABBV) is a prominent global biopharmaceutical company that focuses on discovering, developing, manufacturing, and commercializing drugs for the treatment of chronic and complex diseases.  In July 2024, AbbVie received approval from the European Commission for SKYRIZI to treat adult patients with moderately to severely active ulcerative colitis. Additionally, the company submitted applications to the U.S. FDA and the European Medicines Agency for a new indication of upadacitinib (RINVOQ) to treat adult patients with giant cell arteritis.

Recently, in August, the company acquired Cerevel Therapeutics, which is a biotechnology and pharmaceutical company. Financially, AbbVie Inc. (NYSE:ABBV) reported revenues of $14.462 billion for the second quarter, which is up from $13.865 billion in the same period last year. Total operating costs and expenses for the quarter were $10.464 billion, compared to $9.352 billion the previous year. Operating earnings were $3.998 billion, down from $4.513 billion in Q2 2023. AbbVie’s net earnings for the quarter were $1.373 billion, down from $2.027 billion in the same quarter the previous year. Net earnings attributable to AbbVie Inc. (NYSE:ABBV) were $1.370 billion. The immunology segment delivered total revenues of approximately $7 billion, with strong performance from Skyrizi and Rinvoq.

On the other hand, UnitedHealth Group Incorporated (NYSE:UNH) is also one of the biggest healthcare companies in the world. UnitedHealthcare has announced plans to offer individual and family plans on the Health Insurance Marketplace in 26 states for 2024, focusing on affordable coverage and access to care. The company has invested $180,000 in the United Disabilities Services Foundation to support aging and disability services in Pennsylvania. Financially, UnitedHealth Group reported total revenues of $98.9 billion in Q2 2024, marking a 6.4% increase year-over-year which is driven primarily by robust performance in its Optum and UnitedHealthcare divisions. The Optum segment generated revenues of $62.9 billion, reflecting an 11.7% year-over-year growth.

This growth was supported by strong contributions from Optum Health and Optum Rx, with Optum Health nearing 5 million patients in value-based care arrangements by year-end. UnitedHealth Group Incorporated (NYSE:UNH) reported adjusted earnings per share (EPS) of $6.80 in the same period, which exceeded analysts’ expectations and represented a 10.7% increase from the previous year. However, GAAP earnings per share were impacted by the cyberattack, coming in at $4.54. UnitedHealth Group Incorporated (NYSE:UNH) updated its full-year net EPS guidance to a range of $15.95 to $16.40 per share, while reaffirming its adjusted EPS outlook of $27.50 to $28.00. The company remains optimistic about its growth prospects, particularly in the Medicare Advantage sector.

AUNA, a Latin American Health Company, Makes its Debut in Global Equity Market

In March, 2024, Auna S.A. (NYSE:AUNA) became the first Latin American health company to be listed in the US stock exchange. Auna operates in Mexico, Columbia and Peru. It raised $300 million in gross proceeds after issuing 30 million Class-A shares. The company is primarily focused on prevention and treatment of high-complexity diseases in the region.

Auna S.A. (NYSE:AUNA)’s 2023 revenues were US$1.05 billion and Adjusted EBITDA was US$223 million, representing year-over-year increases of 58% and 90%, respectively. Auna S.A. (NYSE:AUNA) is likely to benefit a lot from a healthcare market of US$313 billion in Spanish-speaking South American countries, it is estimated to grow further to reach US$469 billion by the end of 2028.

While we acknowledge the potential of AUNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TSLA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ ALSO: Top 20 Largest Publicly Traded Healthcare Companies and 10 Best Healthcare Stocks to Buy Under $20.

Pixabay/Public Domain

Our Methodology 

For our list, we looked at two indexes: the GHS index of 2021 and the health pillar of the Legatum Prosperity index of 2023. The 2021 Global Health Security (GHS) Index assesses 195 countries’ preparedness for epidemics and pandemics across six categories. The global average score is 38.9, indicating weak international readiness despite COVID-19 efforts. Similarly, The Health pillar of the 2023 Legatum Prosperity Index assesses health outcomes, systems, risk factors, and mortality rates, highlighting the importance of physical and mental health and access to effective healthcare services for individual and national prosperity. Hence, we averaged the scores of GHS, and the health pillar’s from Legatum index and the final rankings in our list were adjusted according to the post-normalization average rankings we obtained from our two sources. We call these Insider-Monkey Scores.

“At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).”

Here is our list of the 15 unhealthiest countries in Latin America.

15. Brazil   

Insider Monkey Score: 13.5

The life expectancy at birth in Brazil is around 76 years, which is five years lower than the OECD average of 81 years. Women in Brazil have a life expectancy of 80 years, while men have a life expectancy of 72 years. In 2023, Brazil allocated 10.7% of its GDP to healthcare, approximately $161 billion. This is a high rate compared to Latin America but still a lot of work needs to be done. Per capita spending was about $1,258.

14. Nicaragua   

Insider Monkey Score: 13.5

The life expectancy in Nicaragua, as of 2023, is 74.8 years, which is lower than the average for Latin America. This reflects the broader health challenges faced by the country, including high rates of non-communicable diseases (NCDs) such as obesity and diabetes. For instance, 32.1% of adult women and 20.6% of adult men are living with obesity, and diabetes affects 12.5% of adult women and 10.5% of adult men, according to data from the Global Nutrition Report.

13. Mexico  

Insider Monkey Score: 12.5

The life expectancy in Mexico is approximately 75 years, which is six years lower than the OECD average of 81 years. Women in Mexico tend to live longer than men, with a life expectancy of 78 years compared to 72 years for men. However, Mexican women spend more years in poor health conditions compared to men, with an estimated 11.8 years spent with some disease or disability.

In 2022, Mexico’s health spending per capita was $1,181, less than half of Chile’s and below the OECD’s recommended 6% of GDP, with Mexico spending 5.5%. Medication was the largest household health expense at 43%, followed by hospital services at 15%. The Mexican health system faces challenges like obesity, diabetes, and health inequity, with 14% of the population lacking financial protection. Nearly 70% were covered by public health insurance in 2020, and the System of Social Protection in Health (SPSS) provides care for those not covered by Social Security.

12. Paraguay   

Insider Monkey Score: 11.5

The prevalence of obesity is a huge concern in Paraguay, with a national obesity rate of 15.1% and even higher rates in certain areas, such as Limpio, where it reaches 26.5%. In 2021, Paraguay’s health spending reached 8% of GDP, the highest in a decade, but dropped to $0 in 2022. Public health expenditure was 4.12% of GDP in 2020, with out-of-pocket spending at 38.37%. The healthcare system faces challenges such as access gaps, discrimination, and shortages. Rising healthcare costs and a growing middle class have increased demand for affordable health insurance. By 2024, average spending per capita in Paraguay’s health insurance market is expected to be $50.86, with the market volume projected to reach $412.10 million by 2028.

11. Dominican Republic   

Insider Monkey Score: 9.5

As of 2024, the life expectancy at birth in the Dominican Republic is estimated to be 72.6 years for the total population, with 71 years for males and 74.4 years for females. This is lower than the average life expectancy for the Americas. In 2021, 23.9% of the population lived in poverty, and 3.1% lived in extreme poverty, indicating a slight increase due to the COVID-19 pandemic.

10. Ecuador   

Insider Monkey Score: 9.5

Ecuador stands tenth among the unhealthiest countries in Latin America. Since 2021, Ecuador’s health spending has ranged from 6–8% of GDP, with public spending at 4.97% of GDP in 2020 and out-of-pocket costs at 33.83% of total health expenditure. Ecuador’s publicly funded healthcare system provides free care to all residents, but access remains limited, especially in rural areas and among indigenous populations. Ecuador spends significantly less on healthcare per capita than the U.S., with fewer hospital beds and doctors. Health spending is projected to increase by $3.2 billion between 2024 and 2029, reaching $13.85 billion in 2029.

9. Belize   

Insider Monkey Score: 8

The life expectancy in Belize was 74.9 years as of 2021, which is lower than the average for the Region of the Americas. In 2021, Belize’s healthcare spending was 5% of GDP, consistent since 2014. Per capita health expenditure rose to $310 from $173 in 2002. Out-of-pocket spending reached $28 million, 5% of total health expenditure, continuing its rise since 2010. Government health spending has also increased, covering 71.8% of total health spending in 2020, reducing the financial burden on individuals.

8. Suriname   

Insider Monkey Score: 8

The prevalence of obesity is notably high in Suriname, with 36.7% of adult women and 21.5% of adult men being classified as obese. Diabetes is also prevalent, which affects 15.4% of adult women and 12.5% of adult men, contributing to the country’s health burden. The life expectancy in Suriname is 72.8 years as of 2023, which is lower than the average for the Region of the Americas but has improved by 7.3 years since 2000. In 2021, Suriname’s health spending was about 5% of GDP, reflecting a general increase since 2002. In 2020, public health spending was 4.38% of GDP, with out-of-pocket costs making up 20.52% of total health spending.

7. Guyana   

Insider Monkey Score: 7

Guyana stands seventh among the unhealthiest countries in Latin America. The Indo-Guyanese and Afro-Guyanese populations, which form the majority, experience high rates of hypertension and diabetes, particularly among those over 50 years old. In 2021, Guyana’s health spending was 5% of GDP, down from 6% in 2020, with public health spending at 4.02% of GDP. In 2024, Guyana allocated $620.86 million to health, aiming to improve standards and resources. The World Bank prioritized health in its 2023-2026 engagement with Guyana, focusing on public health preparedness.

6. Venezuela   

Insider Monkey Score: 6.5

The Venezuelan healthcare system has faced a collapse due to ongoing political and economic crises which has led to a resurgence of communicable diseases that were previously under control, such as measles, malaria, and diphtheria. In 2021, Venezuela’s healthcare spending was 4% of GDP, down from 7% earlier in the decade, below the WHO’s 5% recommendation. Public health spending was 1.68% of GDP, with out-of-pocket costs rising to 28% of total health spending. The healthcare system struggles with shortages of surgical supplies, food insecurity, and water shortages, worsening conditions for patients, particularly children under two.

5. El Salvador   

Insider Monkey Score: 6.5

Conditions such as diabetes, hypertension, and chronic kidney disease are the most common in El Salvador. For instance, there are approximately 487,875 cases of diabetes mellitus, 1,446,381 cases of hypertension, and 459,114 cases of chronic kidney disease nationwide. In 2021, El Salvador’s health spending was 10% of GDP, well above the regional average of 3.8%. In 2022, the health budget was $1.09 billion, mainly funded by the government, with contributions from foreign loans and donations. The government also relied on international aid and loans to manage the pandemic.

4. Honduras   

Insider Monkey Score: 5

Honduras is a low-middle-income country with over 60% of its population living in poverty.  The country experiences a double burden of malnutrition, with 23% of children under five experiencing stunting due to chronic malnutrition, while 51% of women of reproductive age are overweight or obese, according to USAID data. There are only 3.9 physicians per 10,000 individuals in the country, far below the World Health Organization’s recommended 25 per 10,000. As of May 31, 2024, Honduras’s health expenditure was 9.2% of GDP, up from 9.1% in 2021, the highest since 2010, which marks a two-percentage-point increase since 2017 when it was nearly 7%.

3. Guatemala    

Insider Monkey Score: 4

Life expectancy in Guatemala is relatively low compared to other Latin American countries. As of 2024, the life expectancy at birth is estimated at 73.5 years, with males having a life expectancy of 71.5 years and females 75.6 years. A significant portion of the population lacks access to basic health and nutrition services, with more than six million people, or about 35% of the population, affected, per figures from USAID. In 2023, Guatemala’s Ministry of Health allocated $6.4 million to UNICEF for health and nutrition programs. In 2021, household out-of-pocket health spending reached $3.66 billion, with per capita health expenditure rising to $341 from $107 in 2002.

2. Bolivia   

Insider Monkey Score: 4

Malnutrition is a significant issue in Bolivia, with 7% of children under five and 23% of the population suffering from malnutrition. Additionally, less than 10% of rural Bolivians have access to improved sanitation facilities. Bolivia ranks poorly in reproductive health, fulfilling only 58% of what is expected based on its income. The country has a high fertility rate of approximately three children per woman, sustained by limited access to family planning services. Contraceptive use is low, with only 35% of married women using modern methods, according to PRB.org.

1. Haiti

Insider Monkey Score: 1

Haiti tops the list for being the unhealthiest country in Latin America. Haiti faces numerous health challenges, including low access to primary and preventive healthcare, high infant and maternal mortality rates, and a lack of vaccination coverage. Only 68% of children under 24 months have received vaccines for diseases like diphtheria, tetanus, and pertussis, according to the World Bank. The average life expectancy in Haiti is approximately 50 years, which is significantly lower than the regional average. In 2023, Haiti’s health spending is $1.07 billion, or $93.87 per capita, making up 7% of GDP. This is relatively low compared to other low-income countries, where average spending is around $13 per person. More than half of Haiti’s health budget is spent on curative rather than preventive care. Health spending as a percentage of GDP has decreased from 4% in 2019 to 3% in 2021, though international aid and private funds can raise this percentage.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure. None: The 15 Unhealthiest Countries in Latin America is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…